Response to the Letter to the Editor

Ehsan Bahramali ¹^*, Negar Firouzabadi ²

¹ Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
² Department of Pharmacology & Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran

*Corresponding Author: *Corresponding Author: Ehsan Bahramali, MD; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran. Email: , Email: ebahramali@gmail.com

Cite this article as: Bahramali E, Firouzabadi N. Response to the letter to the editor. Arch Iran Med. 2018;21(10):489.

First Name

Last Name

Email Address

Comments

Security code

Generate New Image

Type the code from the image

Abstract View: 1550

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2024	12	14	22	15	5	15	9
2023	28	22	11	13	15	21	14	17	20	17	30	19
2022	20	31	26	15	21	21	21	16	28	26	28	16
2021	22	25	16	21	30	28	21	22	30	22	26	25
2020	21	19	20	32	36	19	25	24	22	20	21	13
2019	37	25	25	25	30	20	27	30	20	20	20	28
2018											45	50